PPM1D Mutations in Patients with Hematolymphoid Neoplasms

被引：0

作者：

Streich, Lukas ^{[1
]}

Fisher-Campbell, Nora ^{[1
]}

Magallanes-Hoyos, M. Cristina ^{[1
]}

Gandhi, Arpita ^{[1
]}

Li, Peng ^{[2
]}

Wang, Sa ^{[3
]}

Tang, Guilin ^{[3
]}

Wang, Wei ^{[3
]}

Wiszniewska, Joanna ^{[1
]}

Dunlap, Jennifer ^{[1
]}

Raess, Phil ^{[1
]}

Williams, Todd ^{[1
]}

Press, Richard ^{[1
]}

Fan, Guang ^{[1
]}

Xie, Wei ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR USA

[2] Univ Utah, ARUP Labs, Salt Lake City, UT USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1197

引用

页码：S1244 / S1245

页数：2

共 50 条

[41] RE: PPM1D Mutations in Circulating White Blood Cells and the Risk for Ovarian Cancer Response
Narod, Steven
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (04):
[42] Biallelic null mutations in PPM1D cause a novel combined immunodeficiency with severe neurodevelopmental defects
Sole, Ana Esteve
Gonzalez-Granado, Luis Ignacio
Boast, Brigette
Niemela, Julie E.
Stoddart, Jennifer L.
Silva, Agustin G.
Pias, Leticia
Bolasell, Merce
Marin, Ana V.
Regueiro, Jose R.
Alsina, Laia
Martine, Pierre
Brown, Kate
Apella, Ettore
Francisco Quesada, Juan
Sweeney, Colin L.
Malech, Harry
Haigh, Cathryn L.
Kueh, HyeSun
Rosenzweig, Sergio
CLINICAL IMMUNOLOGY, 2024, 262
[43] The rate of MEFV gene mutations in hematolymphoid neoplasms
Celik, S.
Erikci, A. A.
Tunca, Y.
Sayan, O.
Terekeci, H. M.
Umur, E. E.
Torun, D.
Tangi, F.
Top, C.
Oktenli, C.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2010, 37 (05) : 387 - 391
[44] Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Swisher, Elizabeth M.
Harrell, Maria I.
Norquist, Barbara M.
Walsh, Tom
Brady, Mark
Lee, Ming
Hershberg, Robert
Kalli, Kimberly R.
Lankes, Heather
Konnick, Eric Q.
Pritchard, Colin C.
Monk, Bradley J.
Chan, John K.
Burger, Robert
Kaufmann, Scott H.
Birrer, Michael J.
JAMA ONCOLOGY, 2016, 2 (03) : 370 - 372
[45] PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
Nathan R. Fons
Ranjini K. Sundaram
Gregory A. Breuer
Sen Peng
Ryan L. McLean
Aravind N. Kalathil
Mark S. Schmidt
Diana M. Carvalho
Alan Mackay
Chris Jones
Ángel M. Carcaboso
Javad Nazarian
Michael E. Berens
Charles Brenner
Ranjit S. Bindra
Nature Communications, 10
[46] PPM1D/WIP1, a potential target in neuroblastoma
Milosevic, Jelena
Wickstrom, Malin
Treis, Diana
Nordegren, Hjalmar Stahlberg
Elfman, Lotta
Baryawno, Ninib
Fransson, Susanne
Sveinbjornsson, Baldur
Martinsson, Tommy
Johnsen, John Inge
Kogner, Per
CANCER RESEARCH, 2014, 74 (19)
[47] Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas
Liwei Zhang
Lee H Chen
Hong Wan
Rui Yang
Zhaohui Wang
Jie Feng
Shaohua Yang
Siân Jones
Sizhen Wang
Weixin Zhou
Huishan Zhu
Patrick J Killela
Junting Zhang
Zhen Wu
Guilin Li
Shuyu Hao
Yu Wang
Joseph B Webb
Henry S Friedman
Allan H Friedman
Roger E McLendon
Yiping He
Zachary J Reitman
Darell D Bigner
Hai Yan
Nature Genetics, 2014, 46 : 726 - 730
[48] Old age and chemotherapy contribute to the selection of PPM1D somatic mosaic mutations in ovarian cancer
Harrell, Maria I.
Norquist, Barbara M.
Walsh, Tom
Brady, Mark F.
Lee, Ming K.
Hershberg, Robert
Kalli, Kimberly R.
Lankes, Heather
Konnick, Eric Q.
Pritchard, Colin C.
Monk, Bradley J.
Chan, John K.
Burger, Robert
Kaufmann, Scott H.
Birrer, Michael J.
Swisher, Elizabeth M.
CLINICAL CANCER RESEARCH, 2016, 22
[49] PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
Zhang, Linda
Hsu, Joanne I.
Goodell, Margaret A.
MOLECULAR CANCER RESEARCH, 2022, 20 (09) : 1365 - 1378
[50] PPM1D Is a Therapeutic Target in Childhood Neural Tumors
Milosevic, Jelena
Treis, Diana
Fransson, Susanne
Gallo-Oller, Gabriel
Sveinbjoernsson, Baldur
Eissler, Nina
Tanino, Keiji
Sakaguchi, Kazuyasu
Martinsson, Tommy
Wickstroem, Malin
Kogner, Per
Johnsen, John Inge
CANCERS, 2021, 13 (23)

← 1 2 3 4 5 →